Security
Merit Medical Systems, Inc. Common Stock · MMSI
MMSINASDAQCommon stockCurrentCIK 856982Updated Oct 30, 2026
MMSI price & chart
Loading TradingView…
NASDAQ:MMSI on TradingView ↗About the company
Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling approximately 900 individuals. Merit employs approximately 7,500 people worldwide.
In the news
Merit Medical to Participate in Upcoming Investors Conferences in September ↗
Seeking Alpha
Merit Medical Systems: A Solid Q3, While Adding New Growth Engines ↗
Merit Medical targets $4.33-$4.37 non-GAAP EPS in 2026 while adding Solo Pace for ~$45M ↗
Merit Medical Systems, Inc. (MMSI) Q3 2026 Earnings Call Transcript ↗
SEC disclosures
MERIT MEDICAL SYSTEMS INC files 8-K: Material Event ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
4 filing
144 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 2,630,998,000Source | 2,378,084,000Source | 2,863,620,000Source | 2,586,045,000Source | 2,371,839,000Source | 2,719,284,000Source | 2,467,973,000Source | 2,326,352,000Source | 2,685,922,000Source | 2,418,603,000Source | 2,325,244,000Source | 1,663,966,000Source |
| Property, Plant and Equipment, NetUSD | 418,004,000Source | 389,653,000Source | 436,749,000Source | 409,985,000Source | 385,939,000Source | 433,957,000Source | 390,324,000Source | 383,661,000Source | 428,401,000Source | 386,165,000Source | 383,523,000Source | 382,976,000Source |
| GoodwillUSD | 507,427,000Source | 399,448,000Source | 539,772,000Source | 504,555,000Source | 381,433,000Source | 503,432,000Source | 464,360,000Source | 381,539,000Source | 506,837,000Source | 463,511,000Source | 382,240,000Source | 359,821,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 392,457,000Source | 523,128,000Source | 448,699,000Source | 341,819,000Source | 636,658,000Source | 488,080,000Source | 395,529,000Source | 581,921,000Source | 446,404,000Source | 376,715,000Source | 587,036,000Source | 58,408,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 210,292,000Source | 189,831,000Source | 224,237,000Source | 204,162,000Source | 182,415,000Source | 206,446,000Source | 199,550,000Source | 180,663,000Source | 203,710,000Source | 190,243,000Source | 177,885,000Source | 164,677,000Source |
| Inventory, NetUSD | 326,550,000Source | 310,527,000Source | 374,112,000Source | 323,309,000Source | 298,224,000Source | 352,386,000Source | 317,936,000Source | 302,733,000Source | 333,705,000Source | 306,063,000Source | 303,871,000Source | 265,991,000Source |
| Assets, CurrentUSD | 985,533,000Source | 1,078,317,000Source | 1,112,238,000Source | 923,072,000Source | 1,162,546,000Source | 1,101,774,000Source | 958,635,000Source | 1,105,275,000Source | 1,040,154,000Source | 923,774,000Source | 1,108,470,000Source | 529,084,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 31,369,000Source | 27,105,000Source | 33,496,000Source | 30,162,000Source | 26,179,000Source | 29,274,000Source | 25,007,000Source | 24,437,000Source | 31,493,000Source | 28,544,000Source | 24,286,000Source | 22,324,000Source |
| Operating Lease, Right-of-Use AssetUSD | 88,496,000Source | 68,867,000Source | 83,776,000Source | 89,279,000Source | 69,903,000Source | 86,376,000Source | 87,722,000Source | 72,639,000Source | 87,600,000Source | 65,508,000Source | 63,047,000Source | 65,262,000Source |
| Other Assets, NoncurrentUSD | 76,854,000Source | 62,382,000Source | 71,859,000Source | 80,753,000Source | 61,583,000Source | 74,665,000Source | 71,856,000Source | 58,682,000Source | 78,227,000Source | 65,336,000Source | 54,793,000Source | 44,352,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,101,590,000Source | 1,054,678,000Source | 1,183,816,000Source | 1,097,997,000Source | 1,089,394,000Source | 1,092,556,000Source | 1,039,550,000Source | 1,086,162,000Source | 1,101,619,000Source | 1,039,244,000Source | 1,123,244,000Source | 519,569,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 747,103,000Source | 669,207,000Source | 783,892,000Source | 734,841,000Source | 658,724,000Source | 769,271,000Source | 718,111,000Source | 649,222,000Source | 763,909,000Source | 703,219,000Source | 638,150,000Source | 675,174,000Source |
| Retained Earnings (Accumulated Deficit)USD | 786,024,000Source | 667,594,000Source | 903,828,000Source | 758,269,000Source | 639,150,000Source | 865,025,000Source | 725,688,000Source | 603,424,000Source | 824,030,000Source | 695,541,000Source | 575,184,000Source | 480,773,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -3,719,000Source | -13,395,000Source | -7,916,000Source | -5,062,000Source | -15,429,000Source | -7,568,000Source | -15,376,000Source | -12,456,000Source | -3,636,000Source | -19,401,000Source | -11,334,000Source | -11,550,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,529,408,000Source | 1,323,406,000Source | 1,679,804,000Source | 1,488,048,000Source | 1,282,445,000Source | 1,626,728,000Source | 1,428,423,000Source | 1,240,190,000Source | 1,584,303,000Source | 1,379,359,000Source | 1,202,000,000Source | 1,144,397,000Source |
| Liabilities and EquityUSD | 2,630,998,000Source | 2,378,084,000Source | 2,863,620,000Source | 2,586,045,000Source | 2,371,839,000Source | 2,719,284,000Source | 2,467,973,000Source | 2,326,352,000Source | 2,685,922,000Source | 2,418,603,000Source | 2,325,244,000Source | 1,663,966,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 230,475,000Source | 201,079,000Source | 264,933,000Source | 225,572,000Source | 186,215,000Source | 216,874,000Source | 196,823,000Source | 183,344,000Source | 239,764,000Source | 216,402,000Source | 203,564,000Source | 220,645,000Source |
| Operating Lease, Liability, CurrentUSD | 10,612,000Source | 11,469,000Source | 10,921,000Source | 10,262,000Source | 11,743,000Source | 11,228,000Source | 9,435,000Source | 12,472,000Source | 10,876,000Source | 10,331,000Source | 12,087,000Source | 11,005,000Source |
| Operating Lease, Liability, NoncurrentUSD | 77,624,000Source | 57,178,000Source | 72,942,000Source | 78,496,000Source | 58,036,000Source | 75,175,000Source | 77,549,000Source | 60,141,000Source | 76,658,000Source | 54,783,000Source | 56,259,000Source | 59,736,000Source |
| Deferred Income Tax Liabilities, NetUSD | 26,707,000Source | 5,571,000Source | 39,704,000Source | 26,925,000Source | 5,510,000Source | 19,664,000Source | 247,000Source | 5,519,000Source | 19,665,000Source | 240,000Source | 5,547,000Source | 18,462,000Source |
| Other Liabilities, NoncurrentUSD | 13,192,000Source | 17,341,000Source | 47,087,000Source | 11,790,000Source | 15,912,000Source | 24,689,000Source | 12,047,000Source | 14,956,000Source | 10,306,000Source | 15,451,000Source | 13,830,000Source | 14,736,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 147,377,000Source | 127,255,000Source | 172,185,000Source | 140,204,000Source | 117,574,000Source | 122,515,000Source | 118,679,000Source | 113,220,000Source | 159,486,000Source | 134,077,000Source | 120,447,000Source | 123,189,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 12,616,000Source | — | — | 11,863,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 732,916,000Source | 750,505,000Source | 736,258,000Source | 731,795,000Source | 801,321,000Source | 735,160,000Source | 730,673,000Source | 800,136,000Source | 734,038,000Source | 729,551,000Source | 823,013,000Source | 186,759,000Source |
| Long-term Debt, Current MaturitiesUSD | — | — | — | — | — | — | — | — | — | — | — | 11,250,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 732,916,000Source | 750,505,000Source | 736,258,000Source | 731,795,000Source | 801,321,000Source | 735,160,000Source | 730,673,000Source | 800,136,000Source | 734,038,000Source | 729,551,000Source | 823,013,000Source | 186,759,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 31,316,000Source | 26,403,000Source | 31,000,000Source | 31,000,000Source | 30,496,000Source | 29,292,000Source | 123,168,000Source | 102,709,000Source | 89,985,000Source | 81,804,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 8,961,000Source | 9,078,000Source | 43,460,000Source | 28,473,000Source | 21,333,000Source | 18,042,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 3,577,000Source | 7,560,000Source | 7,341,000Source | 13,686,000Source | 11,916,000Source | 15,116,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 22,655,000Source | 10,599,000Source | 21,602,000Source | 2,287,000Source | 32,105,000Source | 47,929,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 5,214,000Source | -14,873,000Source | -12,643,000Source | -14,924,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 40,681,000Source | 40,572,000Source | 297,371,000Source | 220,799,000Source | 145,151,000Source | 114,291,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | 1,000,000Source | 1,000,000Source | 144,769,000Source | 320,182,000Source | 138,278,000Source | 8,287,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 7,734,000Source | -29,635,000Source | -247,386,000Source | -368,653,000Source | -175,347,000Source | -57,397,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 16,009,000Source | 21,061,000Source | 81,716,000Source | 35,140,000Source | 34,290,000Source | 45,029,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -6,289,000Source | 6,955,000Source | 15,999,000Source | -60,008,000Source | 559,266,000Source | -60,260,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 260,143,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 41,700,000Source | 18,828,000Source | 69,782,000Source | -210,377,000Source | 528,586,000Source | -7,192,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 394,561,000Source | 525,277,000Source | 450,906,000Source | 343,915,000Source | 490,249,000Source | 397,595,000Source | 448,549,000Source | 378,767,000Source | 589,144,000Source | 60,558,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 10,718,000Source | 12,361,000Source | 20,991,000Source | 23,244,000Source | 14,051,000Source | 6,258,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 4,382,000Source | 3,784,000Source | 31,392,000Source | 45,047,000Source | 31,534,000Source | 17,092,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 13,612,000Source | 6,713,000Source | 12,915,000Source | 10,873,000Source | 8,961,000Source | 9,078,000Source | 43,460,000Source | 28,473,000Source | 21,333,000Source | 18,042,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | — | — | — | 1,717,000Source | 604,000Source |
| Amortization of Intangible AssetsUSD | — | — | 21,800,000Source | 16,900,000Source | 21,200,000Source | 21,500,000Source | 20,700,000Source | 20,000,000Source | 85,100,000Source | 65,600,000Source | 56,100,000Source | 48,400,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 38,200,000Source | 37,200,000Source | 34,000,000Source | 33,400,000Source |
| Equity Method Investment, Other than Temporary ImpairmentUSD | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | — |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | — | — | — | -67,000Source | -87,000Source | -2,302,000Source | -1,490,000Source | -5,838,000Source | -380,000Source |
| Gain (Loss) on Disposition of BusinessUSD | — | — | — | — | — | — | 12,502,000Source | — | 249,000Source | — | 431,000Source | -1,417,000Source |
| GoodwillUSD | — | — | 507,427,000Source | 399,448,000Source | 539,772,000Source | 504,555,000Source | 503,432,000Source | 464,360,000Source | 506,837,000Source | 463,511,000Source | 382,240,000Source | 359,821,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | 137,000Source | 32,000Source | 313,000Source | 456,000Source | 506,000Source | 2,281,000Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 1,700,000Source |
| Income Tax Expense (Benefit)USD | — | — | 10,785,000Source | 8,213,000Source | 12,511,000Source | 10,798,000Source | 12,551,000Source | 7,811,000Source | 42,448,000Source | 29,636,000Source | 17,678,000Source | 8,113,000Source |
| InterestExpenseNonoperatingUSD | — | — | 6,754,000Source | 7,501,000Source | 12,118,000Source | 6,775,000Source | 6,526,000Source | 6,568,000Source | 26,461,000Source | 31,219,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 27,755,000Source | 28,444,000Source | 38,803,000Source | 32,581,000Source | 40,995,000Source | 30,147,000Source | 128,489,000Source | 120,357,000Source | 94,411,000Source | 74,516,000Source |
| Nonoperating Income (Expense)USD | — | — | -4,072,000Source | -604,000Source | -9,089,000Source | -3,501,000Source | 9,389,000Source | -3,075,000Source | -13,783,000Source | -5,700,000Source | -11,855,000Source | -4,934,000Source |
| Operating ExpensesUSD | — | — | 143,799,000Source | 120,274,000Source | 154,763,000Source | 137,607,000Source | 140,640,000Source | 130,987,000Source | 553,550,000Source | 487,640,000Source | 459,928,000Source | 431,536,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 14,219,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 0Source |
| Other Nonoperating Income (Expense)USD | — | — | -933,000Source | 245,000Source | -723,000Source | -487,000Source | 12,015,000Source | -297,000Source | -2,392,000Source | -711,000Source | 1,200,000Source | 966,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 2,775,000Source | 13,152,000Source | 28,213,000Source | 40,908,000Source | 15,584,000Source | 20,070,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 215,205,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | 26,838,000Source | 39,746,000Source | 14,503,000Source | 18,952,000Source |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | — | — | 185,000Source | 189,000Source | 694,000Source | 741,000Source | -89,000Source | 268,000Source | 1,259,000Source | 798,000Source | 287,000Source | 82,000Source |
| Amortization of Debt Issuance Costs and Discounts | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | — | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 384,157,000Source | 339,845,000Source | 418,843,000Source | 382,462,000Source | 381,877,000Source | 355,351,000Source | 1,515,906,000Source | 1,356,514,000Source | 1,257,366,000Source | 1,150,981,000Source |
| Cost of RevenueUSD | — | — | 197,746,000Source | 182,310,000Source | 203,677,000Source | 197,975,000Source | 197,080,000Source | 183,331,000Source | 777,636,000Source | 713,181,000Source | 673,494,000Source | 631,882,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 119,801,000Source | 99,644,000Source | 129,229,000Source | 113,097,000Source | 118,210,000Source | 107,486,000Source | 455,214,000Source | 399,731,000Source | 373,676,000Source | 342,525,000Source |
| Operating Income (Loss)USD | — | — | 42,612,000Source | 37,261,000Source | 60,403,000Source | 46,880,000Source | 44,157,000Source | 41,033,000Source | 184,720,000Source | 155,693,000Source | 123,944,000Source | 87,563,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -933,000Source | 245,000Source | -723,000Source | -487,000Source | 12,015,000Source | -297,000Source | -2,392,000Source | -711,000Source | 1,200,000Source | 966,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 38,540,000Source | 36,657,000Source | 51,314,000Source | 43,379,000Source | 53,546,000Source | 37,958,000Source | 170,937,000Source | 149,993,000Source | 112,089,000Source | 82,629,000Source |
| Income Tax Expense (Benefit)USD | — | — | 10,785,000Source | 8,213,000Source | 12,511,000Source | 10,798,000Source | 12,551,000Source | 7,811,000Source | 42,448,000Source | 29,636,000Source | 17,678,000Source | 8,113,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 27,755,000Source | 28,444,000Source | 38,803,000Source | 32,581,000Source | 40,995,000Source | 30,147,000Source | 128,489,000Source | 120,357,000Source | 94,411,000Source | 74,516,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.47Source | 0.49Source | 0.65Source | 0.55Source | 0.69Source | 0.51Source | 2.17Source | 2.07Source | 1.64Source | 1.31Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.46Source | 0.48Source | 0.65Source | 0.54Source | 0.68Source | 0.49Source | 2.13Source | 2.03Source | 1.62Source | 1.29Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 59,245,000Source | 58,231,000Source | 59,679,000Source | 59,140,000Source | 59,510,000Source | 58,897,000Source | 59,158,000Source | 58,218,000Source | 57,593,000Source | 56,806,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 59,919,000Source | 59,537,000Source | 60,006,000Source | 60,611,000Source | 60,013,000Source | 61,278,000Source | 60,460,000Source | 59,365,000Source | 58,356,000Source | 57,671,000Source |
| Interest Expense (non-operating)USD | — | — | 6,754,000Source | 7,501,000Source | 12,118,000Source | 6,775,000Source | 6,526,000Source | 6,568,000Source | 26,461,000Source | 31,219,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 21,800,000Source | 16,900,000Source | 21,200,000Source | 21,500,000Source | 20,700,000Source | 20,000,000Source | 85,100,000Source | 65,600,000Source | 56,100,000Source | 48,400,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 37,234,000Source | 44,509,000Source | 30,321,000Source | 23,037,000Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — | 0Source | 0Source | 0Source |
| Gross ProfitUSD | — | — | 186,411,000Source | 157,535,000Source | 215,166,000Source | 184,487,000Source | 184,797,000Source | 172,020,000Source | 738,270,000Source | 643,333,000Source | 583,872,000Source | 519,099,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 110,396,000Source | 93,687,000Source | 60,935,000Source | 77,562,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 15,511,000Source | 6,339,000Source |
| Investment Income, NetUSD | — | — | 3,615,000Source | 6,652,000Source | 3,752,000Source | 3,761,000Source | 3,900,000Source | 3,790,000Source | 15,070,000Source | 26,230,000Source | 2,456,000Source | 439,000Source |
| Nonoperating Income (Expense)USD | — | — | -4,072,000Source | -604,000Source | -9,089,000Source | -3,501,000Source | 9,389,000Source | -3,075,000Source | -13,783,000Source | -5,700,000Source | -11,855,000Source | -4,934,000Source |
| Operating ExpensesUSD | — | — | 143,799,000Source | 120,274,000Source | 154,763,000Source | 137,607,000Source | 140,640,000Source | 130,987,000Source | 553,550,000Source | 487,640,000Source | 459,928,000Source | 431,536,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 14,219,000Source |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | — | —Source | — | — | — | — | — |
Filing attachments
mmsi-ex99d1.htm · 8-K · 2026-10-29
Exhibit 99.1 Contacts: PR/Media Inquiries: Investor Inquiries: Sarah Comstock Mike Piccinino, CFA, IRC Merit Medical ICR Healthcare +1-801-432-2864 +1-443-213-0509 sarah.comstock@merit.com mike.piccinino@icrhealthcare.com FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS THIRD QUARTER 2026 RESULTS: DELIVERS 9% ORGANIC CONSTANT CURRENCY REVENUE GROWTH AND RAISES FULL-YEAR 2026 GUIDANCE Financial Highlights† Reported reve…
Read attachment ↗mmsi-ex99d2.htm · 8-K · 2026-10-29
Exhibit 99.2 1 Merit Medical Investor Call October 29, 2026 Third Quarter 2026 Results Martha Aronson President and CEO Raul Parra CFO ─────────────────────────────── 2 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among oth…
Read attachment ↗mmsi-20260814xex99d1.htm · 8-K · 2026-08-20
EX-99.1 3 mmsi-20260814xex99d1.htm EX-99.1 Exhibit 99.1 Merit Medical Announces Global Operations Leadership Transition SOUTH JORDAN, Utah, August 19, 2026 (GLOBE NEWSWIRE) - Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed to join Merit as Executive Vice President of Global Operations, effective August 31, 2026. Ms. Lewis brings three decades of experience across global operations, manufacturin…
Read attachment ↗mmsi-20260730xex99d1.htm · 8-K · 2026-07-30
EX-99.1 2 mmsi-20260730xex99d1.htm EX-99.1 Exhibit 99.1 Contacts: PR/Media Inquiries: Investor Inquiries: Sarah Comstock Mike Piccinino, CFA, IRC Merit Medical ICR Healthcare +1-801-432-2864 +1-443-213-0509 sarah.comstock@merit.com mike.piccinino@icrhealthcare.com FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS SECOND QUARTER 2026 RESULTS AND UPDATES FULL-YEAR 2026 GUIDANCE Financial Highlights† Reported revenue o…
Read attachment ↗mmsi-20260730xex99d2.htm · 8-K · 2026-07-30
EX-99.2 3 mmsi-20260730xex99d2.htm EX-99.2 Exhibit 99.2 1 Merit Medical Investor Call July 30, 2026 Second Quarter 2026 Results Martha Aronson President and CEO Raul Parra CFO ─────────────────────────────── 2 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Fo…
Read attachment ↗mmsi-20260513xex99d1.htm · 8-K · 2026-05-19
EX-99.1 5 mmsi-20260513xex99d1.htm EX-99.1 Exhibit 99.1 SUMMARY OF MERIT MEDICAL SYSTEMS, INC. 2026 EQUITY INCENTIVE PLAN The following is a brief description of the principal features of the Merit Medical Systems, Inc. 2026 Equity Incentive Plan (the “2026 Equity Incentive Plan”). This summary does not contain all of the terms and conditions of the 2026 Equity Incentive Plan and is qualified in its entirety by reference to the full text of the 2026 Equity Incentive Plan which is included …
Read attachment ↗